Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction

Journal of the American College of Cardiology

Volumn 44, Issue 3, 2004, Pages 564-568

  Sadanandan, Saihari ^a,e   Cannon, Christopher P ^b   Chekuri, Kasi ^a   Murphy, Sabina A ^b   Dibattiste, Peter M ^c   Morrow, David A ^b   De Lemos, James A ^d   Braunwald, Eugene ^b   Gibson, C Michael ^b  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

B type natriuretic peptide; BNP; CAD; coronary artery disease; corrected TIMI frame count; CTFC; LAD; left anterior descending coronary artery; left ventricular; LV; non ST segment elevation myocardial infarction; NSTEMI; STEMI

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ST SEGMENT ELEVATION; STENOSIS; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; SEVERITY OF ILLNESS INDEX;

EID: 4043152160     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.03.072     Document Type: Article

References (24)

1. Wiese S., Breyer T., Dragu A., et al. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium Influence of angiotensin 2 and diastolic fiber length. Circulation. 102:2000;3074-3079
2. Cowie M.R., Mendex G.F. BNP and congestive heart failure. Prog Cardiovasc Dis. 44:2002;293-321
3. McCullough P.A., Maisel A.S. BNP Multinational Study Investigators. B-type natriuretic peptide and clinical judgement in emergency diagnosis of heart failure. Circulation. 106:2002;416-422
4. Morita E., Yasue H., Yoshimura M., et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation. 88:1993;82-91
5. Arakawa N., Nakamura M., Aoki H., Hiramori K. Relationship between plasma level of brain natriuretic peptide and myocardial infarct size. Cardiology. 85:1994;334-340
6. Arakawa N., Nakamura M., Aoki H., Hiramori K. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol. 27:1996;1656-1661
7. Nagaya N., Nishikimi T., Goto Y., et al. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction. Am Heart J. 135:1998;21-28
8. Yoshitomi Y., Nishikimi T., Kojima S., et al. Plasma natriuretic peptides as indicators of left ventricular remodeling after myocardial infarction. Int J Cardiol. 64:1998;153-160
9. Bettencourt P., Ferreira A., Pardal-Oliveira N., et al. Clinical significance of brain natriuretic peptide in patients with postmyocardial infarction. Clin Cardiol. 23:2000;921-927
10. Kikuta K., Yasue H., Yoshimura M., et al. Increased plasma levels of B-type natriuretic peptide in patients with unstable angina. Am Heart J. 132:1996;101-107
11. Talwar S., Squire I.B., Downei P.F., Davies J.E., Ng L.L. Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart. 84:2000;421-424
12. de Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 345:2001;1014-1021
13. Morrow D.A., de Lemos J.A., Cannon C.P., Sabatine M.S., et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/Non-ST-elevation myocardial infarction. J Am Coll Cardiol. 41:2003;1264-1272
14. Jernberg T., Stridsberg M., Venge P., Lindahl B. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol. 40:2002;437-445
15. Omland T., Persson A., Ng L., et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation. 106:2002;2913-2918
16. James S.K., Lindahl B., Siegbahn A., et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease. Circulation. 108:2003;275-281
17. Cannon C.P., Weintraub W.S., Demopoulos L.A., et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 344:2001;1879-1887
18. Group T.T.S. TIMI Study Group. The Thrombolysis In Myocardial Infarction (TIMI) trial Phase i findings. N Engl J Med. 312:1985;932-936
19. Gibson C.M., Cannon C.P., Daley W.L., et al. TIMI frame count A quantitative method of assessing coronary artery flow. Circulation. 93:1996;879-888
20. Morrow D.A., Braunwald E. Future of biomarkers in acute coronary syndromes - moving toward a multimarker strategy. Circulation. 108:2003;250-252
21. de Lemos J.A., Morrow D.A. B-type natriuretic peptide measurement in acute coronary syndromes Ready for clinical application? Circulation. 106:2002;2868-2870
22. Marumoto K., Hamada M., Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischemia induced by dynamic exercise in patients with angina pectoris. Clin Sci (Lond). 88:1995;551-556
23. Kyriakides Z.S., Markianos M., Michalis L., et al. Brain natriuretic peptide increases acutely and much more prominently than atrial natriuretic peptide during coronary angioplasty. Clin Cardiol. 23:2000;285-288
24. Tateishi J., Masutani M., Ohyanagi M., Iwasaki T. Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol. 23:2000;776-780